South San Francisco, CA, United States of America

Claudio Aquino

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2022)
  • Newark, CA (US) (2022)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Claudio Aquino

Introduction

Claudio Aquino is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate IL-17A, which is crucial for treating various inflammatory conditions.

Latest Patents

Aquino holds four patents, with his latest innovations focusing on substituted benzenecarboxamides as IL-17A modulators. These compounds and pharmaceutical compositions are designed for the modulation of IL-17A, which can be beneficial in treating inflammatory conditions such as psoriasis. Additionally, he has developed novel ligands and pharmaceutical compositions that also modulate IL-17A, providing methods for preparing these modulators. Such compounds may be useful in the treatment and prevention of inflammation, cancer, or autoimmune diseases.

Career Highlights

Claudio Aquino is currently associated with Dice Alpha, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing therapeutic options for patients suffering from various inflammatory and autoimmune conditions.

Collaborations

Aquino has collaborated with notable colleagues, including Paul Ross Fatheree and Martin Sheringham Linsell, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Claudio Aquino's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and ongoing research are paving the way for new treatments that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…